Anna Sleder1,2, Shiloh Tackett3, Matthew Cerasale3, Chetan Mittal4, Iyad Isseh3, Ryhm Radjef3, Andrew Taylor5, Rashad Farha3, Oleksandra Lupak3, Dana Larkin5, Lois Lamerato5, George Divine5, Kimberlydawn Wisdom6, Kimberly Baker-Genaw3, William O'Neill7. 1. Formerly Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA. Anna.Sleder@stvincent.org. 2. Cardiovascular Services, St. Vincent Hospital, 8333 Naab Road, Ste 400, Indianapolis, IN, 46260, USA. Anna.Sleder@stvincent.org. 3. Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA. 4. Department of Medicine, University of Colorado, Denver, CO, USA. 5. Department of Public Health Sciences, Henry Ford Health System, Detroit, MI, USA. 6. Community Health and Equity, Henry Ford Health System, Detroit, MI, USA. 7. Heart and Vascular Institute, Henry Ford Hospital, Detroit, MI, USA.
Abstract
BACKGROUND: We sought to quantify socioeconomic disparities in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) at an urban, tertiary referral center. METHODS: This retrospective case-control study identified 67 patients with severe AS (aortic valve [AV] area ≤1 cm2 or AV area index ≤0.60 cm2/m2 or AV velocity ≥40 mmHg) who underwent TAVR from November 5, 2013 to June 10, 2014. Study subjects were matched to controls with severe AS without TAVR in a 4:1 age-frequency match. Demographic data were collected using electronic medical records. Area-based median household income was obtained by geocoding patients' addresses and linking with census data. Charlson comorbidity index for all subjects was calculated. RESULTS: Income disparity was significant in that with every $10,000 increase in income, the odds of receiving TAVR increased by 10% (p = 0.05). Non-blacks were significantly more likely to receive TAVR than blacks (odds ratio [OR] 2.812, confidence interval [CI] 1.007-7.853; p = 0.048). No differences in comorbidities were found between the two groups. Post hoc analysis to identify etiologies of the found disparities examined differences of AV area and AV area index, indication for two-dimensional echocardiography (echo), symptoms prior to echo, and action after echo within the control group. Black race significantly impacted the TAVR status despite the same AV area (OR 0.33, CI 0.09-0.97, p = 0.043). After echo, blacks were more likely to decline AVR, be lost to follow-up, and not be referred to cardiology (OR 4.41, CI 1.43-13.64; p = 0.010). CONCLUSION: Socioeconomic and racial disparities were associated with patients with severe AS receiving TAVR at a major referral center. This study emphasizes the importance of improving access to standard of care for these subgroups of cardiac patients.
BACKGROUND: We sought to quantify socioeconomic disparities in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) at an urban, tertiary referral center. METHODS: This retrospective case-control study identified 67 patients with severe AS (aortic valve [AV] area ≤1 cm2 or AV area index ≤0.60 cm2/m2 or AV velocity ≥40 mmHg) who underwent TAVR from November 5, 2013 to June 10, 2014. Study subjects were matched to controls with severe AS without TAVR in a 4:1 age-frequency match. Demographic data were collected using electronic medical records. Area-based median household income was obtained by geocoding patients' addresses and linking with census data. Charlson comorbidity index for all subjects was calculated. RESULTS: Income disparity was significant in that with every $10,000 increase in income, the odds of receiving TAVR increased by 10% (p = 0.05). Non-blacks were significantly more likely to receive TAVR than blacks (odds ratio [OR] 2.812, confidence interval [CI] 1.007-7.853; p = 0.048). No differences in comorbidities were found between the two groups. Post hoc analysis to identify etiologies of the found disparities examined differences of AV area and AV area index, indication for two-dimensional echocardiography (echo), symptoms prior to echo, and action after echo within the control group. Black race significantly impacted the TAVR status despite the same AV area (OR 0.33, CI 0.09-0.97, p = 0.043). After echo, blacks were more likely to decline AVR, be lost to follow-up, and not be referred to cardiology (OR 4.41, CI 1.43-13.64; p = 0.010). CONCLUSION: Socioeconomic and racial disparities were associated with patients with severe AS receiving TAVR at a major referral center. This study emphasizes the importance of improving access to standard of care for these subgroups of cardiac patients.
Authors: Kathryn M Rose; Randi E Foraker; Gerardo Heiss; Wayne D Rosamond; Chirayath M Suchindran; Eric A Whitsel Journal: Ann Epidemiol Date: 2012-07-17 Impact factor: 3.797
Authors: Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas Journal: Circulation Date: 2014-03-03 Impact factor: 29.690
Authors: Sa'ar Minha; Israel M Barbash; Marco A Magalhaes; Itsik Ben-Dor; Petros G Okubagzi; Lakshmana K Pendyala; Lowell F Satler; Augusto D Pichard; Rebecca Torguson; Ron Waksman Journal: Catheter Cardiovasc Interv Date: 2014-05-20 Impact factor: 2.692
Authors: John P Vavalle; Harry R Phillips; Sara A Holleran; Andrew Wang; Christopher M O'Connor; Peter K Smith; G Chad Hughes; J Kevin Harrison; Manesh R Patel Journal: Am J Cardiol Date: 2014-03-22 Impact factor: 2.778
Authors: Devin K Patel; Kelly D Green; Marat Fudim; Frank E Harrell; Thomas J Wang; Mark A Robbins Journal: J Am Heart Assoc Date: 2014-05-28 Impact factor: 5.501
Authors: Tamunoinemi Bob-Manuel; Arindam Sharma; Amit Nanda; Devarshi Ardeshna; William Paul Skelton; Rami N Khouzam Journal: Ann Transl Med Date: 2018-01
Authors: Dagmar F Hernandez-Suarez; Sagar Ranka; Pedro Villablanca; Nicole Yordan-Lopez; Lorena González-Sepúlveda; Jose Wiley; Cristina Sanina; Abiel Roche-Lima; Brenda G Nieves-Rodriguez; Stacey Thomas; Pedro Cox-Alomar; Angel Lopez-Candales; Harish Ramakrishna Journal: Cardiovasc Revasc Med Date: 2019-04-09
Authors: Andi Shahu; Jeph Herrin; Sanket S Dhruva; Nihar R Desai; Barry R Davis; Harlan M Krumholz; Erica S Spatz Journal: J Am Heart Assoc Date: 2019-07-31 Impact factor: 5.501
Authors: Elizabeth Golembiewski; Katie S Allen; Amber M Blackmon; Rachel J Hinrichs; Joshua R Vest Journal: JMIR Public Health Surveill Date: 2019-10-07
Authors: Safi U Khan; Ankur Kalra; Samir R Kapadia; Muhammad U Khan; Muhammad Zia Khan; Muhammad Shahzeb Khan; Mamas A Mamas; Haider J Warraich; Khurram Nasir; Erin D Michos; Mohamad Alkhouli Journal: J Am Heart Assoc Date: 2020-10-19 Impact factor: 5.501
Authors: Nananda F Col; Diana Otero; Brian R Lindman; Aaron Horne; Melissa M Levack; Long Ngo; Kimberly Goodloe; Susan Strong; Elvin Kaplan; Melissa Beaudry; Megan Coylewright Journal: PLoS One Date: 2022-08-11 Impact factor: 3.752
Authors: J Matthew Brennan; Martin B Leon; Paige Sheridan; Isabel J Boero; Qinyu Chen; Angela Lowenstern; Vinod Thourani; Sreekanth Vemulapalli; Kevin Thomas; Tracy Y Wang; Eric D Peterson Journal: J Am Heart Assoc Date: 2020-08-11 Impact factor: 5.501
Authors: Sandra B Lauck; Suzanne J Baron; William Irish; Britt Borregaard; Kimberly A Moore; Candace L Gunnarsson; Seth Clancy; David A Wood; Vinod H Thourani; John G Webb; Harindra C Wijeysundera Journal: J Am Heart Assoc Date: 2021-09-28 Impact factor: 5.501